Lifespan®
A drug for the treatment of remitting multiple sclerosis
Dosage form
tablets No.30, capsules No.30
Active substance
fingolimod
Dosage
0,5 mg
In connection with the letter of the Federal Service for Supervision of Healthcare (Roszdravnadzor) No.11-41143/21 dated 07/23/2021 "On the request for a risk management plan for the drug Lifespan", JSC Valenta Pharm publishes educational materials for doctors and patients approved by Roszdravnadzor
Educational materials: